Assessing the Impact of Dosage Frequency of Propranolol on Sleep Patterns in Patients With Infantile Hemangiomas

Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 4
SUMMARY

The purpose of this study is to assess the baseline sleep pattern disruption for patients starting oral propranolol at the standard BID dosing regimen compared to the control (timolol) group and to determine if there is a significant improvement in the sleep patterns in infants taking oral propranolol on the TID dosing regimen versus the control (timolol) group

Eligibility
Participation Requirements
Sex: All
Maximum Age: 1
Healthy Volunteers: No
View:

• clinically diagnosed hemangiomas.

• English or Spanish speaking only

Locations
United States
Texas
The University of Texas Health Science Center at Houston
Recruiting
Houston
Contact Information
Primary
Matthew R Greives, MD
Matthew.R.Greives@uth.tmc.edu
713-500-7275
Backup
Chioma Obinero
Chioma.G.Obinero@uth.tmc.edu
713-500-7216
Time Frame
Start Date: June 23, 2022
Estimated Completion Date: December 31, 2023
Participants
Target number of participants: 174
Treatments
Experimental: ter in die (TID)three times a day
Experimental: bis in die (BID)twice a day
Active Comparator: Control
Authors
Matthew R Greives
Sponsors
Leads: The University of Texas Health Science Center, Houston

This content was sourced from clinicaltrials.gov

Similar Clinical Trials